Valuation: OneSource Specialty Pharma Limited

Market Cap 157B 1.65B 1.47B 1.36B 1.24B 2.33B 2.37B 16.37B 6.44B 81.91B 6.2B 6.07B 262B P/E 2027 *
33.7x
P/E 2028 * 16.3x
Enterprise Value 166B 1.75B 1.56B 1.44B 1.31B 2.46B 2.5B 17.3B 6.8B 86.54B 6.55B 6.41B 277B EV / Sales 2027 *
7.6x
EV / Sales 2028 * 4.64x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day-2.93%
1 week-6.48%
Current month-10.19%
1 month-14.31%
3 months-17.34%
6 months-11.46%
Current year-24.52%
1 week 1,352.3
Extreme 1352.3
1,478.1
1 month 1,352.3
Extreme 1352.3
1,643
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Chairman 65 22/09/2025
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.93%-6.48%-25.34% - 1.7B
+1.52%-7.16%+51.66%+67.41% 65B
+1.52%+6.83%+10.89%+79.30% 51.2B
+0.30%-0.46%-0.03%+61.89% 51.19B
-0.70%+1.00%+24.89%+41.81% 43.93B
+0.52%+5.82%+16.39%+133.69% 41.96B
+2.69%-5.63%+238.87%+531.12% 38.14B
+2.16%+10.36%+18.92%+59.70% 33.24B
-0.90%-10.49%+37.09%+1.80% 25.2B
+1.60%+2.21%+27.96%+28.00% 22.5B
Average +0.52%-0.24%+40.13%+111.63% 37.41B
Weighted average by Cap. +0.91%+0.02%+45.33%+112.72%

Financials

2027 *2028 *
Net sales 21.8B 230M 205M 190M 173M 324M 329M 2.28B 895M 11.39B 863M 845M 36.42B 34.02B 359M 320M 296M 269M 506M 514M 3.55B 1.4B 17.78B 1.35B 1.32B 56.84B
Net income 4.46B 47.03M 41.92M 38.84M 35.31M 66.26M 67.35M 466M 183M 2.33B 176M 173M 7.45B 8.97B 94.59M 84.32M 78.11M 71.02M 133M 135M 937M 368M 4.69B 355M 347M 14.98B
Net Debt 8.86B 93.41M 83.26M 77.13M 70.13M 132M 134M 925M 364M 4.63B 350M 343M 14.8B 1.16B 12.28M 10.94M 10.14M 9.22M 17.3M 17.58M 122M 47.81M 608M 46.06M 45.1M 1.94B
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
19/10/26 ₹1,366.60 -2.93% 92,387
16/10/26 ₹1,407.80 -1.77% 103,563
15/10/26 ₹1,433.20 -0.64% 85,979
14/10/26 ₹1,442.40 -1.14% 303,380
13/10/26 ₹1,459.10 -0.81% 228,818
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,366.60INR
Average target price
2,056.00INR
Spread / Average Target
+50.45%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock